See more : Sacgasco Limited (SGC.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Beiersdorf Aktiengesellschaft (BDRFY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beiersdorf Aktiengesellschaft, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Administradora de Fondos de Pensiones Habitat S.A. (HABITAT.SN) Income Statement Analysis – Financial Results
- Phol Dhanya Public Company Limited (PHOL.BK) Income Statement Analysis – Financial Results
- Julius Bär Gruppe AG (0QO6.L) Income Statement Analysis – Financial Results
- Adamant DRI Processing and Minerals Group (ADMG) Income Statement Analysis – Financial Results
- Biocure Technology Inc. (CURE.CN) Income Statement Analysis – Financial Results
Beiersdorf Aktiengesellschaft (BDRFY)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.beiersdorf.com
About Beiersdorf Aktiengesellschaft
Beiersdorf Aktiengesellschaft engages in the manufacture and distribution of consumer goods in Europe, the Americas, Africa, Asia, and Australia. It operates in two segments, Consumer Business and Tesa Business. The Consumer Business Segment offers skin and body care products. The Tesa Business segment provides adhesive tapes and self-adhesive products and system solutions for industries, craft businesses, and consumers. This segment offers its system solutions to the automotive, electronics, printing and paper, and building and construction industries. It offers its products under the NIVEA, Eucerin, La Prairie, Labello, Hansaplast, 8x4, FLORENA, Coppertone, HIDROFUGAL, GAMMON, SKIN STORIES, FLORENA FERMENTED SKINCARE, STOP THE WATER WHILE USING ME, CHAUL, TESA, O.W.N., Chantecaille, Elastoplast, CURITAS, and Beiersdorf brands. The company was founded in 1882 and is headquartered in Hamburg, Germany. Beiersdorf Aktiengesellschaft is a subsidiary of maxingvest ag.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.45B | 8.80B | 7.63B | 7.03B | 7.65B | 7.23B | 7.06B | 6.75B | 6.69B | 6.29B | 6.14B | 6.04B | 5.63B | 6.19B | 5.75B | 5.97B | 5.51B | 5.12B | 4.78B | 4.55B | 4.67B | 4.74B |
Cost of Revenue | 4.03B | 3.84B | 3.27B | 2.98B | 3.22B | 3.08B | 2.91B | 2.77B | 2.79B | 2.37B | 2.26B | 2.22B | 2.08B | 2.02B | 1.88B | 1.98B | 1.83B | -1.74B | -1.66B | -1.61B | 1.70B | 1.76B |
Gross Profit | 5.42B | 4.96B | 4.36B | 4.04B | 4.43B | 4.16B | 4.15B | 3.98B | 3.90B | 3.92B | 3.89B | 3.82B | 3.56B | 4.18B | 3.87B | 3.99B | 3.68B | 6.86B | 6.43B | 6.16B | 2.98B | 2.99B |
Gross Profit Ratio | 57.33% | 56.34% | 57.17% | 57.52% | 57.91% | 57.49% | 58.76% | 58.92% | 58.35% | 62.34% | 63.28% | 63.29% | 63.13% | 67.45% | 67.26% | 66.86% | 66.77% | 133.91% | 134.72% | 135.48% | 63.66% | 62.97% |
Research & Development | 320.00M | 291.00M | 268.00M | 246.00M | 236.00M | 211.00M | 196.00M | 188.00M | 183.00M | 168.00M | 154.00M | 159.00M | 163.00M | 152.00M | 149.00M | 149.00M | 127.00M | -118.00M | -109.00M | -101.00M | 100.00M | 93.00M |
General & Administrative | 570.00M | 524.00M | 448.00M | 400.00M | 416.00M | 404.00M | 395.00M | 364.00M | 366.00M | 330.00M | 312.00M | 311.00M | 293.00M | 278.00M | 283.00M | 292.00M | 260.00M | 245.00M | 0.00 | 0.00 | 251.00M | 260.00M |
Selling & Marketing | 3.25B | 3.00B | 2.68B | 2.49B | 2.67B | 2.48B | 2.47B | 2.41B | 2.43B | 2.60B | 2.61B | 2.54B | 2.45B | 2.96B | 2.77B | 2.87B | 2.62B | -2.41B | -2.20B | -2.09B | 2.09B | 2.10B |
SG&A | 3.83B | 3.52B | 3.12B | 2.89B | 3.08B | 2.89B | 2.87B | 2.77B | 2.80B | 2.93B | 2.92B | 2.85B | 2.75B | 3.24B | 3.05B | 3.17B | 2.88B | -2.41B | -2.20B | -2.09B | 2.34B | 2.36B |
Other Expenses | 159.00M | -56.00M | -5.00M | 26.00M | 27.00M | -10.00M | 46.00M | -17.00M | -24.00M | -12.00M | -12.00M | -12.00M | -2.00M | -6.00M | -10.00M | -19.00M | 56.00M | 374.00M | 4.00M | 9.00M | 30.00M | 12.00M |
Operating Expenses | 4.31B | 3.76B | 3.39B | 3.16B | 3.35B | 3.09B | 3.06B | 2.94B | 2.96B | 3.13B | 3.06B | 3.04B | 3.13B | 3.60B | 3.28B | 3.30B | 3.06B | -2.53B | -2.31B | -2.19B | 2.49B | 2.51B |
Cost & Expenses | 8.34B | 7.60B | 6.65B | 6.14B | 6.57B | 6.16B | 5.97B | 5.72B | 5.74B | 5.49B | 5.31B | 5.26B | 5.20B | 5.61B | 5.16B | 5.28B | 4.89B | -4.26B | -3.97B | -3.80B | 4.19B | 4.27B |
Interest Income | 43.00M | 36.00M | 32.00M | 33.00M | 37.00M | 35.00M | 35.00M | 30.00M | 25.00M | 32.00M | 23.00M | 37.00M | 31.00M | 19.00M | 21.00M | 55.00M | 72.00M | 38.00M | 0.00 | 0.00 | 3.00M | 11.00M |
Interest Expense | 26.00M | 16.00M | 14.00M | 13.00M | 13.00M | 9.00M | 8.00M | 4.00M | 14.00M | 7.00M | 6.00M | 9.00M | 19.00M | 13.00M | 15.00M | 14.00M | 44.00M | 35.00M | 0.00 | 0.00 | 18.00M | 17.00M |
Depreciation & Amortization | 449.00M | 279.00M | 278.00M | 247.00M | 239.00M | 165.00M | 150.00M | 148.00M | 129.00M | 179.00M | 106.00M | 152.00M | 273.00M | 221.00M | 135.00M | 114.00M | 122.00M | 183.00M | 162.00M | 173.00M | 164.00M | 161.00M |
EBITDA | 1.58B | 1.40B | 1.21B | 1.09B | 1.29B | 1.22B | 1.23B | 1.18B | 1.08B | 997.00M | 934.00M | 874.00M | 732.00M | 787.00M | 733.00M | 849.00M | 777.00M | 1.07B | 4.13B | 3.97B | 681.00M | 656.00M |
EBITDA Ratio | 16.72% | 16.46% | 16.55% | 16.26% | 17.40% | 16.72% | 16.77% | 18.05% | 16.42% | 15.94% | 15.39% | 15.15% | 12.99% | 12.71% | 12.75% | 14.22% | 14.71% | 86.84% | 86.45% | 87.42% | 14.57% | 13.83% |
Operating Income | 1.11B | 1.09B | 933.00M | 828.00M | 1.03B | 1.10B | 1.09B | 1.02B | 962.00M | 796.00M | 820.00M | 698.00M | 431.00M | 583.00M | 587.00M | 797.00M | 616.00M | 477.00M | 531.00M | 483.00M | 484.00M | 472.00M |
Operating Income Ratio | 11.70% | 12.41% | 12.23% | 11.79% | 13.48% | 15.17% | 15.42% | 15.03% | 14.39% | 12.67% | 13.35% | 11.56% | 7.65% | 9.41% | 10.21% | 13.35% | 11.19% | 9.32% | 11.12% | 10.62% | 10.36% | 9.95% |
Total Other Income/Expenses | 0.00 | 4.00M | -26.00M | -7.00M | 5.00M | -49.00M | -66.00M | 25.00M | 6.00M | 15.00M | -5.00M | -85.00M | 9.00M | -30.00M | -4.00M | 25.00M | 28.00M | 374.00M | 4.00M | 9.00M | 15.00M | 6.00M |
Income Before Tax | 1.11B | 1.10B | 907.00M | 821.00M | 1.04B | 1.05B | 1.02B | 1.04B | 968.00M | 811.00M | 815.00M | 709.00M | 440.00M | 553.00M | 583.00M | 822.00M | 644.00M | 851.00M | 535.00M | 492.00M | 499.00M | 478.00M |
Income Before Tax Ratio | 11.70% | 12.46% | 11.89% | 11.69% | 13.55% | 14.49% | 14.48% | 15.40% | 14.48% | 12.90% | 13.27% | 11.74% | 7.81% | 8.93% | 10.14% | 13.77% | 11.69% | 16.62% | 11.20% | 10.82% | 10.68% | 10.08% |
Income Tax Expense | 356.00M | 325.00M | 252.00M | 244.00M | 301.00M | 303.00M | 333.00M | 313.00M | 297.00M | 274.00M | 272.00M | 258.00M | 181.00M | 227.00M | 203.00M | 255.00M | 202.00M | 183.00M | 200.00M | 190.00M | 198.00M | 188.00M |
Net Income | 736.00M | 755.00M | 638.00M | 560.00M | 718.00M | 728.00M | 672.00M | 709.00M | 660.00M | 529.00M | 534.00M | 445.00M | 250.00M | 318.00M | 374.00M | 562.00M | 437.00M | 664.00M | 329.00M | 296.00M | 294.00M | 283.00M |
Net Income Ratio | 7.79% | 8.58% | 8.37% | 7.97% | 9.38% | 10.06% | 9.52% | 10.50% | 9.87% | 8.42% | 8.70% | 7.37% | 4.44% | 5.13% | 6.51% | 9.41% | 7.94% | 12.97% | 6.89% | 6.51% | 6.29% | 5.97% |
EPS | 3.24 | 3.33 | 2.81 | 2.47 | 3.17 | 0.64 | 0.59 | 0.63 | 0.58 | 0.47 | 0.47 | 0.39 | 0.23 | 0.29 | 0.34 | 0.50 | 0.39 | 0.59 | 0.29 | 0.26 | 0.23 | 0.23 |
EPS Diluted | 3.24 | 3.33 | 2.81 | 2.47 | 3.17 | 0.64 | 0.59 | 0.63 | 0.58 | 0.47 | 0.47 | 0.39 | 0.23 | 0.29 | 0.34 | 0.50 | 0.39 | 0.59 | 0.29 | 0.26 | 0.23 | 0.23 |
Weighted Avg Shares Out | 226.82M | 226.82M | 226.82M | 226.82M | 226.82M | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.26B | 1.26B |
Weighted Avg Shares Out (Dil) | 226.82M | 226.82M | 226.82M | 226.82M | 226.82M | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B | 1.26B | 1.26B |
Beiersdorf Aktiengesellschaft (BDRFF) Q3 2024 Earnings Call Transcript
Beiersdorf Aktiengesellschaft (BDRFF) Q2 2024 Earnings Call Transcript
3 Beauty and Cosmetics Stocks to Invest In for Glowing Returns
Beiersdorf warns of slowing sales growth
Beiersdorf Aktiengesellschaft (BDRFF) Q3 2023 Earnings Call Transcript
Beiersdorf Aktiengesellschaft (BDRFF) Q2 2023 Earnings Call Transcript
Beiersdorf Aktiengesellschaft (BDRFF) Q1 2023 Earnings Call Transcript
Beiersdorf Aktiengesellschaft (BDRFF) Q3 2022 Earnings Call Transcript
Beiersdorf Aktiengesellschaft (BDRFF) CEO Vincent Warnery on Q2 2022 Results - Earnings Call Transcript
Beiersdorf posts 10.5% organic sales growth in H1, affirms outlook
Source: https://incomestatements.info
Category: Stock Reports